Time Course Change in Skeletal Muscle and Blood Phospholipid Composition With Omega-3 Fatty Acid Supplementation
Condition(s):Skeletal Muscle Fatty Acid MetabolismLast Updated:January 19, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Skeletal Muscle Fatty Acid MetabolismLast Updated:January 19, 2024Recruiting
Condition(s):Cancer of Digestive SystemLast Updated:August 25, 2022Terminated
Condition(s):Rheumatoid Arthritis; Healthy ControlsLast Updated:July 13, 2023Completed
Condition(s):Cachexia; Muscle Loss; Muscle Wasting; Muscle Atrophy; Critical IllnessLast Updated:July 8, 2021Completed
Condition(s):Advanced Lung Cancer; SarcopeniaLast Updated:March 22, 2024Recruiting
Condition(s):Heart FailureLast Updated:August 23, 2018Unknown status
Condition(s):Skeletal MuscleLast Updated:February 6, 2024Active, not recruiting
Condition(s):Skeletal Muscle Damage; Skeletal Muscle Performance; Intgracellular Signaling in Skeletal Muscle; Inflammatory StatusLast Updated:January 29, 2013Completed
Condition(s):Muscular DystrophyLast Updated:January 14, 2020Terminated
Condition(s):Skeletal Muscle Mitochondrial Dysfunction in the ElderlyLast Updated:June 23, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.